Clinical Significance of c-met Oncogene Alterations in Human Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|56|4|314-321

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.4, 1999-05, pp. : 314-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C‐Met in invasive breast cancer

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 163-171

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 8, 2015-04 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

c-Met Expression in Gastric Cancer with Liver Metastasis

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 286-296

Karger

Access to resources Recommend Favorite

Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 475-481

Karger

Access to resources Recommend Favorite

Clinical Significance of Nuclear Morphometry at the Invasive Front of T1 Colorectal Cancer and Relation to Expression of VEGF-A and VEGF-C

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 230-238

Karger

Access to resources Recommend Favorite